TA-65

In August 2012, a class action was brought on behalf of New Yorkers claiming, among other things, that the makers of pill, TA-65, which is marketed as an anti-aging supplement, “have failed to reasonably warn consumers of the potential dangerous consequences associated with TA-65 telomerase activation and malignant tumor formation.”  (Egan, et al. v. Telomerase Activation Sciences, Inc. et al., Case No. 652533/2012, S.C.N.Y.)